SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following a preliminary update that revealed record-breaking quarterly orders exceeding 60 billion and gross margins nearly doubling previous guidance. The community is actively discussing the potential for a massive short squeeze as investors weigh these strong profitability signals against historical governance concerns and recent volatility.

Ondas, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Inc.

Ondas Inc

Ondas Inc. is trending as investors react to a significant volume surge and the company securing over $70 million in new defense and autonomous technology contracts. The community is actively discussing the potential for a short squeeze, fueled by high short interest and anticipation surrounding upcoming earnings and defense modernization momentum.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending as investors debate the potential long-term impact of its restrictive search and data licensing strategies against the need for revenue growth. Community sentiment is deeply polarized, with some traders betting on a breakout fueled by AI partnerships, while others express frustration over stock volatility and platform moderation policies.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is facing scrutiny and market volatility due to reported delays in its next-generation Gemini model, fueling community debate about the company's ability to keep pace with rivals in the competitive AI race. Investors are closely watching upcoming earnings for clarity on capital expenditure and whether Google's heavy AI investments are successfully translating into scalable, profitable growth.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is seeing massive, abnormal trading volume and heightened volatility as the community debates the stock's transition toward agentic AI. Investors are closely monitoring the tension between significant institutional accumulation and high short interest, with many hoping that a sustained breakout above key resistance levels could trigger a potential short squeeze.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is surging as escalating military strikes in the Middle East and threats of a maritime blockade in the Strait of Hormuz ignite supply concerns. Investors are actively debating the potential for long-term geopolitical volatility against the backdrop of an ongoing conflict and reports of tightening global energy inventories.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is experiencing significant price volatility following mixed quarterly results, where an earnings miss in the wind segment temporarily overshadowed strong revenue beats and raised full-year guidance. Investors are actively debating whether this pullback is an overreaction to short-term execution hurdles or a necessary correction, with many viewing the company's massive backlog and its critical role in powering the AI infrastructure boom as strong indicators for long-term growth.

AT&T, Inc. is a holding company, which engages in the provision of telecommunications and technology services. It operates through the Communications and Latin America segments. The Communications segment offers wireless, wireline telecom, and broadband services to businesses and consumers located in the US and businesses globally. The Latin America segment provides wireless services and equipment in Mexico. The company was founded in 1983 and is headquartered in Dallas, TX.

AT&T, Inc.

AT&T Inc

AT&T shares are trending following a positive earnings report that highlighted strong subscriber growth in fiber and fixed wireless, helping to alleviate investor concerns regarding long-term competition from satellite services. The community is actively discussing the company's role as foundational infrastructure for AI and the potential impact of its share repurchase program.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is seeing significant market momentum following the release of robust Phase 3 clinical data for its lead drug candidate, plozasiran, which successfully met all primary and secondary endpoints in patients with severe hypertriglyceridemia. Investors and community members are actively discussing the potential for a best-in-class market position and the broader implications for the company's extensive RNAi pipeline as it targets multiple high-value therapeutic indications.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is trading in a volatile range as investors navigate sector-wide software pressure ahead of a highly anticipated earnings report. The community remains deeply divided, with bulls pointing to the company's strong enterprise moat and AI integration potential, while bears express concern over valuation and recent weakness in software sector momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Sarepta Therapeutics to Announce Second Quarter 2026 Financial Results

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, will report second quarter 2026 financial results after the Nasdaq Global Market closes on Wednesday, Aug. 5, 2026. Subsequently, at 4:30 p.m. E.T., the Company will host a conference call to...

SRPT Stock Drops 4% As Citi Flags Potentially Stronger Rival In Duchenne Space

Equity

Citi reiterated a ‘Sell’ rating on SRPT, citing the expected rise in competition within the Duchenne muscular dystrophy (DMD) exon-skipping market.


uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix

QURE is sharpening its gene therapy focus through faster regulatory pathways, a streamlined business model and CNS pipeline expansion, with AMT-130 at the center.

This Analyst Sees 34% Upside For SRPT Stock — Here's Why They Expect A Sustained Rally Next 

Analysts at Wolfe Research upgraded Sarepta to ‘Outperform’ from ‘Peer Perform,’ with a price target of $27.


Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on June 30, 2026 that were previously approved by the Compensation Committee of its Board of Directors under Sareptas 2024 Employment Commencement Incentive Plan, as a...

SRPT Stock Climbs After Sarepta Seeks Permanent FDA Nod For Two Duchenne Therapies

Sarepta is seeking full approval for Amondys 45 and Vyondys 53 in Duchenne muscular dystrophy. 


Sarepta Announces FDA Acceptance of sNDAs for AMONDYS 45 and VYONDYS 53

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Applications (sNDAs) for AMONDYS 45 (casimersen) and VYONDYS 53 (golodirsen) for...

SRPT or PRTA: Which Is the Better Value Stock Right Now?

SRPT vs. PRTA: Which Stock Is the Better Value Option?

All You Need to Know About Sarepta Therapeutics (SRPT) Rating Upgrade to Buy

Sarepta Therapeutics (SRPT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

SRPT vs. ARGX: Which Stock Is the Better Value Option?

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980 and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.22	--	--	N/A
Q1 '26	$0.98	$2.88	195.11%	BEAT
Q4 '25	-$1.20	-$3.93	-228.26%	MISSED
Q3 '25	-$0.73	-$1.80	-147.60%	MISSED
Q2 '25	$0.83	$1.89	127.08%	BEAT

Feed

News

Sentiment

Earnings

Fundamentals

Info

SRPTSarepta Therapeutics Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest SRPT News